Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings.

@article{Clemens2006QuantitativeEE,
  title={Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings.},
  author={B{\'e}la Clemens and Andrea M{\'e}nes and P{\'a}lma Piros and M{\'o}nika Bessenyei and Anna Altmann and Judit Jerney and Katalin Koll{\'a}r and Be{\'a}ta Rosdy and Margit R{\'o}zsav{\"o}lgyi and Katalin Steinecker and Katalin Holl{\'o}dy},
  journal={Epilepsy research},
  year={2006},
  volume={70 2-3},
  pages={190-9}
}
UNLABELLED Quantitative EEG (QEEG) effects of therapeutic doses of carbamazepine (CBZ), oxcarbazepine (OXC), valproate (VA) and lamotrigine (LA) monotherapy were investigated in patients with beginning epilepsy. Baseline waking EEG (EEG1) was recorded in the untreated state, the second EEG (EEG2) was done after 8 weeks of reaching the therapeutic dose. Left occipital data were used for analysis. QEEG target parameters were absolute band-power (delta: AD, theta: AT, alpha: AA, beta: AB), and… CONTINUE READING